Impaired mucosal regeneration in neonatal necrotising enterocolitis

Pediatric Surgery International

Volumn 21, Issue 3, 2005, Pages 153-160

  Vieten, Daniela ^a   Corfield, Anthony ^b   Carroll, Daniel ^a   Ramani, Pramila ^c   Spicer, Richard ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Mucosal restitution repair; Necrotising enterocolitis; Trefoil peptides

Indexed keywords

FORMALDEHYDE; GENE PRODUCT; MESSENGER RNA; PARAFFIN; PEPTIDE; RIBONUCLEASE; TREFOIL PEPTIDE;

APOPTOSIS; CELL MIGRATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ENTEROCOLITIS; EPITHELIUM CELL; GASTROINTESTINAL TRACT; GENE EXPRESSION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE SURGERY; LAPAROTOMY; NECROSIS; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS; UPREGULATION;

ADULT; COLON; ENTEROCOLITIS, NECROTIZING; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC MARKERS; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT, NEWBORN; INTESTINAL MUCOSA; INTESTINE, SMALL; MUCINS; MUSCLE PROTEINS; PEPTIDES; PREGNANCY; PROTEINS; REGENERATION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 16344362162     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-004-1312-6     Document Type: Conference Paper

References (27)

1. BPSU (1997) British Paediatric Surveillance Unit annual report. Commun Dis Rep CDR Wkly 7:453, 456
2. Hsueh W, Caplan MS, Qu X-W, Tan X-D, de Plaen IG, Gonzalez-Crussi F (2002) Neonatal necrotising enterocolitis: clinical considerations and pathogenic concepts. Ped Develop Pathol 6:6-23
3. Podolsky DK (1999) Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am J Physiol 277:G495-G499
4. Taupin D, Podolsky DK (2003) Trefoil factors: initiators of mucosal healing. Nature Rev Mol Cell Biol 4:721-734
5. Podolsky DK (2000) Mechanisms of regulatory peptide action in the gastrointestinal tract: trefoil peptides. J Gastroenterol 35:69-74
6. Kinoshita K, Taupin DR, Itoh H, Podolsky DK (2000) Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20:4680-4690
7. Beck S, Schmitt H, Shizuya H, Blin N, Gott P (1996) Cloning of contiguous genomic fragments from human chromosome 21 harbouring three trefoil peptide genes. Hum Genet 98:233-235
8. Sands BE, Podolsky DE (1996) The trefoil peptide family. Annu Rev Physiol 58:253-273
9. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, Wright NA (2000) Co-ordinated expression of mucin and trefoil peptide genes in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 47:792-800
10. Playford RJ (1995) Peptides and gastrointestinal mucosal integrity. Gut 37:595-597
11. Lin J, Holzman IR, Jiang P, Babyatsky MW (1999) Expression of intestinal trefoil factor in developing rat intestine. Biol Neonate 76:92-97
12. Podolsky DK (2000) Review article: healing after inflammatory injury-coordination of a regulatory peptide network. Aliment Pharmacol Ther 14(suppl 1):87-93
13. Taupin DR, Kinoshita K, Podolsky DK (2000) Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA 97:799-804
14. Kindon H, Pothoulakis H, Thim L, Lynch-Devaney K, Podolsky DK (1995) Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 109:516-523
15. Thim L, Madsen F, Poulsen SS (2002) Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 32:519-527
16. Soriano-Izquierdo A, Gironella M, Massaguer A, May FEB, Salas A, Sans M, Poulsom R, Thim L, Pique JM, Panes J (2004) Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation. J Leukoc Biol 75:214-223
17. Giraud AS, Pereira PM, Thim L, Parker LM, Judd LM (2004) TFF2 inhibits iNOS/NO in monocytes and nitrated protein in healing colon after colitis. Peptides 25:803-809
18. Wright NA, Elia G, Pike C (1990) Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in gastrointestinal stem cells. Nature 343:82-85
19. Longman RJ, Thomas MG, Poulsom R (1999) Trefoil peptides and surgical disease. Br J Surg 86:740-748
20. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Bolton RA, Thim L, Hanby AM (1995) Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108:108-116
21. Babyatsky MW, de Baumont M, Thim L, Podolsky DK (1996) Oral trefoil peptides protect against ethanol and indomethacin-induced gastric injury in rats. Gastroenterology 110:489-497
22. Tran CP, Cook GA, Yeomans ND, Thim L, Giraud AS (1999) Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 44:636-642
23. Tomasetto C, Masson R, Linares JL, Wendling C, Lefebvre O, Chenard MP, Rio MC (2000) pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118:70-80
24. Sands BE, Ogata H, Lynch-Devaney K, deBeaumont M, Ezzell RM, Podolsky DK (1995) Molecular cloning of the rat intestinal trefoil factor gene. Characterization of an intestinal goblet cell-associated promoter. J Biol Chem 270:9353-9361
25. Rio MC, Chenard MP, Wolf C, Marcellin L, Tomasetto C, Lathe R, Bellocq JP, Chambon P (1991) Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100:375-379
26. Elia G, Hanby AM, Poulsom R (1992) A putative human spasmolytic peptide (hSP) antibody and its staining pattern in gastrointestinal epithelium. Gut 33:45
27. Srivatsa G, Giraud AS, Ulaganathan M, Yeomans ND, Dow C, Nicoll AJ (2002) Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology 40:261-268